vs

Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $32.6M, roughly 2.0× RxSight, Inc.). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -28.1%, a 62.1% gap on every dollar of revenue. Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs 5.1%).

Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CAC vs RXST — Head-to-Head

Bigger by revenue
CAC
CAC
2.0× larger
CAC
$64.3M
$32.6M
RXST
Higher net margin
CAC
CAC
62.1% more per $
CAC
34.0%
-28.1%
RXST
Faster 2-yr revenue CAGR
CAC
CAC
Annualised
CAC
22.6%
5.1%
RXST

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CAC
CAC
RXST
RXST
Revenue
$64.3M
$32.6M
Net Profit
$21.9M
$-9.2M
Gross Margin
77.5%
Operating Margin
-34.8%
Net Margin
34.0%
-28.1%
Revenue YoY
-18.9%
Net Profit YoY
-54.1%
EPS (diluted)
$1.29
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAC
CAC
RXST
RXST
Q1 26
$64.3M
Q4 25
$68.1M
$32.6M
Q3 25
$65.4M
$30.3M
Q2 25
$62.3M
$33.6M
Q1 25
$60.1M
$37.9M
Q4 24
$47.6M
$40.2M
Q3 24
$45.0M
$35.3M
Q2 24
$42.8M
$34.9M
Net Profit
CAC
CAC
RXST
RXST
Q1 26
$21.9M
Q4 25
$22.6M
$-9.2M
Q3 25
$21.2M
$-9.8M
Q2 25
$14.1M
$-11.8M
Q1 25
$7.3M
$-8.2M
Q4 24
$14.7M
$-5.9M
Q3 24
$13.1M
$-6.3M
Q2 24
$12.0M
$-6.1M
Gross Margin
CAC
CAC
RXST
RXST
Q1 26
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Operating Margin
CAC
CAC
RXST
RXST
Q1 26
Q4 25
41.5%
-34.8%
Q3 25
40.5%
-40.1%
Q2 25
28.5%
-41.6%
Q1 25
10.3%
-28.2%
Q4 24
38.7%
-21.5%
Q3 24
35.2%
-26.1%
Q2 24
34.7%
-23.9%
Net Margin
CAC
CAC
RXST
RXST
Q1 26
34.0%
Q4 25
33.1%
-28.1%
Q3 25
32.4%
-32.4%
Q2 25
22.6%
-35.0%
Q1 25
12.2%
-21.6%
Q4 24
30.8%
-14.8%
Q3 24
29.1%
-17.9%
Q2 24
28.0%
-17.4%
EPS (diluted)
CAC
CAC
RXST
RXST
Q1 26
$1.29
Q4 25
$1.33
$-0.22
Q3 25
$1.25
$-0.24
Q2 25
$0.83
$-0.29
Q1 25
$0.43
$-0.20
Q4 24
$1.00
$-0.14
Q3 24
$0.90
$-0.16
Q2 24
$0.81
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAC
CAC
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$228.1M
Total DebtLower is stronger
$514.4M
Stockholders' EquityBook value
$710.0M
$275.7M
Total Assets
$7.0B
$311.8M
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAC
CAC
RXST
RXST
Q1 26
Q4 25
$228.1M
Q3 25
$227.5M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$237.1M
Q2 24
$233.3M
Total Debt
CAC
CAC
RXST
RXST
Q1 26
$514.4M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CAC
CAC
RXST
RXST
Q1 26
$710.0M
Q4 25
$696.6M
$275.7M
Q3 25
$676.4M
$276.0M
Q2 25
$652.1M
$278.0M
Q1 25
$640.1M
$279.3M
Q4 24
$531.2M
$281.2M
Q3 24
$529.9M
$277.3M
Q2 24
$508.3M
$275.2M
Total Assets
CAC
CAC
RXST
RXST
Q1 26
$7.0B
Q4 25
$7.0B
$311.8M
Q3 25
$7.0B
$308.5M
Q2 25
$6.9B
$309.0M
Q1 25
$7.0B
$313.0M
Q4 24
$5.8B
$318.6M
Q3 24
$5.7B
$310.5M
Q2 24
$5.7B
$305.5M
Debt / Equity
CAC
CAC
RXST
RXST
Q1 26
0.72×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAC
CAC
RXST
RXST
Operating Cash FlowLast quarter
$-1.1M
Free Cash FlowOCF − Capex
$-2.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAC
CAC
RXST
RXST
Q1 26
Q4 25
$63.9M
$-1.1M
Q3 25
$36.1M
$-1.2M
Q2 25
$6.0M
$-4.4M
Q1 25
$1.0M
$-8.8M
Q4 24
$60.9M
$-4.3M
Q3 24
$-14.5M
$650.0K
Q2 24
$14.5M
$-4.0M
Free Cash Flow
CAC
CAC
RXST
RXST
Q1 26
Q4 25
$58.2M
$-2.3M
Q3 25
$35.4M
$-1.8M
Q2 25
$4.5M
$-5.9M
Q1 25
$-727.0K
$-9.4M
Q4 24
$55.4M
$-5.1M
Q3 24
$-16.2M
$-453.0K
Q2 24
$13.2M
$-5.5M
FCF Margin
CAC
CAC
RXST
RXST
Q1 26
Q4 25
85.5%
-6.9%
Q3 25
54.1%
-5.8%
Q2 25
7.3%
-17.6%
Q1 25
-1.2%
-24.8%
Q4 24
116.4%
-12.7%
Q3 24
-36.0%
-1.3%
Q2 24
30.8%
-15.9%
Capex Intensity
CAC
CAC
RXST
RXST
Q1 26
Q4 25
8.4%
3.5%
Q3 25
1.1%
1.9%
Q2 25
2.4%
4.6%
Q1 25
2.9%
1.5%
Q4 24
11.7%
2.1%
Q3 24
3.8%
3.1%
Q2 24
3.0%
4.4%
Cash Conversion
CAC
CAC
RXST
RXST
Q1 26
Q4 25
2.83×
Q3 25
1.70×
Q2 25
0.43×
Q1 25
0.14×
Q4 24
4.15×
Q3 24
-1.11×
Q2 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAC
CAC

Net Interest Income$52.4M81%
Noninterest Income$12.0M19%

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons